Stem Cell Therapeutics Corp. (“SCT”) (TSX VENTURE:SSS) has closed the previously announced $2.0 Million private placement of 4,000,000 units, each unit consisting of one common share of SCT and one-half of one common share purchase warrant. Each full warrant entitles the holder to purchase one additional common share of SCT for $0.75 for a period of one year from closing or $1.00 for an additional year.
